Whistleblower News: Biogen Inc Agrees To Pay $900M To Settle Allegations Related To Improper Physician Payments, SEC Charges Oracle A Second Time For Violations Of The Foreign Corrupt Practices Act, SEC Settles Insider Trading Charges

Biogen Inc. Agrees to Pay $900 Million to Settle Allegations Related to Improper Physician Payments


Pharmaceutical company Biogen Inc. (Biogen), based in Cambridge, Massachusetts, has agreed to pay $900 million to resolve allegations that it caused the submission of false claims to Medicare and Medicaid by paying kickbacks to physicians to induce them to prescribe Biogen drugs. read more »

SEC Charges Oracle a Second Time for Violations of the Foreign Corrupt Practices Act


The Securities and Exchange Commission announced settled charges requiring Oracle Corporation to pay more than $23 million to resolve charges that it violated provisions of the Foreign Corrupt Practices Act (FCPA) when subsidiaries in Turkey, the United Arab Emirates (UAE), and India created and used slush funds to bribe foreign officials in return for business between 2016 and 2019. read more »

SEC Settles Insider Trading Charges Against Former Investment Banking Analyst and Associate of Former NFL Player


On August 30, 2022, the United States District Court for the Eastern District of Pennsylvania entered final judgments against Damilare Sonoiki, a former investment banking analyst, and Mark Wayne Ramsey, who was a friend, roommate, and business partner of former professional football player Mychal Kendricks. read more »